Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06999954 · ClinicalTrials.gov registry record
Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform
A clinical trial of Exocrine Pancreatic Insufficiency and Shwachman-Diamond Syndrome, sponsored by Shwachman-Diamond Syndrome Alliance.
- Recruiting
- Registry status
- 8,000
- Enrollment target
- 1
- Study location
NCT06999954 is a study of Exocrine Pancreatic Insufficiency and Shwachman-Diamond Syndrome that is actively recruiting participants, run by Shwachman-Diamond Syndrome Alliance. The registered enrollment target is 8,000 participants, above the 83-participant average among 7 other Exocrine Pancreatic Insufficiency trials with a reported enrollment target (9539% higher). The trial reports 1 study location across 1 state.
The verdict
NCT06999954, a study of Exocrine Pancreatic Insufficiency and Shwachman-Diamond Syndrome, is actively recruiting participants, sponsored by Shwachman-Diamond Syndrome Alliance.
- RECRUITING
- Registry status
- 8,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program (SDS-GPS) is an opportunity for patients and their families - from anywhere in the world - to share their experience living with SDS via a safe, secure, and convenient online platform, to * expand the understanding of SDS * improve the lives of people with SDS, and * accelerate the development of new therapies and cures for SDS. By joining, participants will receive early access to relevant information about new clinical trials and other research opportunities (such as clinical registries) based on their profile, accelerating research and increasing clinical trial impact and recruitment success. The platform, consent forms, and surveys are available in five languages: English, Spanish, French, German, and Italian. More languages to come.
Conditions Studied
Study Locations (1)
Massachusetts
- Shwachman-Diamond Syndrome Alliance Inc. - Woburn
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8,000 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2088-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06999954
The ClinicalTrials.gov registry entry for NCT06999954 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 8,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 83-participant average among 7 other Exocrine Pancreatic Insufficiency trials with a reported enrollment target (9539% higher). The listed sponsor is Shwachman-Diamond Syndrome Alliance, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Exocrine Pancreatic Insufficiency appearing as the primary indexed condition, and to 0 interventions.
NCT06999954 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT06999954 about?
NCT06999954 is a clinical study titled "Shwachman-Diamond Syndrome Global Patient Survey and Partnering Platform". The Shwachman-Diamond Syndrome Global Patient Survey and Collaboration Program (SDS-GPS) is an opportunity for patients and their families - from anywhere in the world - to share their experience living with SDS via a safe, secure, and convenient online platform, to * expand the understanding of SD...
What is the current status of trial NCT06999954?
This trial is currently recruiting. The enrollment target is 8,000 participants. The study started on 2024-02-07. Estimated completion is 2088-12.
What conditions does trial NCT06999954 study?
This clinical trial studies the following conditions: Exocrine Pancreatic Insufficiency, Shwachman-Diamond Syndrome, Congenital Neutropenia, SDS, IBMF.
Who is sponsoring clinical trial NCT06999954?
This trial is sponsored by Shwachman-Diamond Syndrome Alliance, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06999954 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Exocrine Pancreatic Insufficiency
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Evaluating the Utility of RELiZORB™ for Treating Feeding Intolerance in Critically Ill Adults With Multi-Organ Failure
RECRUITING · NA
-
THE Malabsorption Blood Test Trial Will Help Determine THE Benefits OF Pancreatic Enzyme Replacement Therapy IN Patients With Mild TO Moderate Exocrine Pancreatic Insufficiency.
RECRUITING · Phase 4
-
Pancreatic Enzyme Replacement Therapy for Acute Pancreatitis-Associated Exocrine Pancreatic Insufficiency
RECRUITING · Phase 4
-
PR-018: An Open-Label, Safety Extension of Study PR-011
COMPLETED · Phase 4
-
Open-Label Phase III Long-Term Safety Trial of Liprotamase
COMPLETED · Phase 3
-
SIMPLICITY: Studying Impacts on Malabsorption With Liprotamase in Cystic Fibrosis
COMPLETED · Phase 3
Explore more on PlainTrial
Exocrine Pancreatic Insufficiency
All registered trials for this condition
Shwachman-Diamond Syndrome
All registered trials for this condition
Massachusetts
All trials with a study site in Massachusetts
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.